Slingshot members are tracking this event:
Amgen And UCB Announce Positive Top-Line Results From The Phase 3 Study Of Romosozumab In Postmenopausal Women With Osteoporosis
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|Community voting in process
Slingshot Insights Explained
Feb 21, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Positive Top-line, Vertebral Fracture, Placebo-controlled Fracture Study